The effect of omeprazole on asthmatic adolescents with gastroesophageal reflux disease
Source: Allergy and Asthma Proceedings, Volume 29, Number 5, September-October 2008 , pp. 517-520(4)
Publisher: OceanSide Publications, Inc
Abstract:The prevalence of gastroesophageal reflux disease (GERD) is increasing in patients with asthma and the effect of proton pump inhibitor therapy on asthma outcome has shown variable results. The aim of this study was to determine the efficacy of omeprazole in the treatment of asthma and improvement of pulmonary function in adolescents with GERD. Thirty-six consecutive patients (range, 13–20 years old) with moderate persistent asthma and GERD were recruited on regular follow-up in Mashhad City. The case group included 18 patients who received oral omeprazole (20 mg twice a day for 6 weeks) and the control group included 18 patients who received placebo. A pulmonary function test was examined in two groups immediately before and 6 weeks after medication. The symptoms of GERD were significantly improved with omeprazole in the case group. After 6 weeks of study, the mean values of forced vital capacity, forced expiratory volume in 1 second, and peak expiratory flow rate were higher in patients treated with omeprazole (p < 0.0001). Treatment by omeprazole is effective for treatment of asthmatic patients with GERD.
Document Type: Research Article
Affiliations: 1: From the Department of Pediatric Gastroenterology, 2: From the Department of Pediatric Gastroenterology, Mashhad University of Medical Sciences, Mashhad, Iran, and 3: Department of Internal Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran 4: Immunology, Asthma and Allergy Research Institute, Children's Medical Center Hospital, Medical Sciences/University of Tehran, Tehran, Iran,
Publication date: September 1, 2008
- Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.
The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma.
Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.
Articles marked "F" offer free full text for personal noncommercial use only.
The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service.
- Editorial Board
- Information for Authors
- Submit a Paper
- Information for Advertisers
- Reprint Requests
- ingentaconnect is not responsible for the content or availability of external websites